Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Potassium chloride + sodium lactate + sodium chloride + calcium chloride + dextrose monohydrate** is a fixed-combination intravenous crystalloid and carbohydrate solution marketed as formulations such as **Lactated Ringer's and Dextrose** and **Potassium Chloride in Lactated Ringer's and 5% Dextrose Injection**. It is a parenteral small-molecule and inorganic salt combination used as a source of water, electrolytes, and calories, and as an alkalinizing agent. Pharmacologically, it replenishes extracellular sodium, potassium, calcium, and chloride, provides lactate that is metabolized to bicarbonate and can help buffer metabolic acidosis, and supplies dextrose as a source of carbohydrate calories. It is used in adults and pediatric patients for fluid and electrolyte replacement, treatment or prevention of dehydration and electrolyte depletion, and support in conditions requiring alkalinization or minimal caloric supplementation. Publicly identified manufacturers and label holders include Pfizer and ICU Medical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on potassium chloride + sodium lactate + sodium chloride + calcium chloride + dextrose monohydrate.